Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (251-260 of 348) with videos related to

Pageof 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 28, 2025
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric AnalysisGeorge J Li, Melissa Sam Soon, Hanbo Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2006
Evaluating mobility for radiotherapy planning of lung tumors: a comparison of virtual fluoroscopy and 4DCTYlanga G van der Geld, Suresh Senan, John R van Sörnsen de Koste, et al.
The Lancet. Oncology|April 24, 2009
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trialCécile Le Péchoux, Ariane Dunant, Suresh Senan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2009
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring studyFemke O B Spoelstra, Suresh Senan, Cecile Le Péchoux, et al.
Journal of Radiation Oncology|August 30, 2016
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challengeEmma Holliday, Clifton D Fuller, Jayashree Kalpathy-Cramer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinomaYlanga G van der Geld, Baukelien van Triest, Wilko F A R Verbakel, et al.
Expert Opinion on Biological Therapy|September 22, 2016
Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Paolo A Ascierto, Massimo C P Barberis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2020
Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastasesJohn R van Sörnsen de Koste, Miguel A Palacios, Hanbo Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung CancerHilâl Tekatli, Niels Haasbeek, Max Dahele, et al.
Chest|May 24, 2014
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysisAlexander V Louie, Suresh Senan, Pretesh Patel, et al.
Pageof 35

Showing results (251-260 of 348) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|June 28, 2025
Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric AnalysisGeorge J Li, Melissa Sam Soon, Hanbo Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2006
Evaluating mobility for radiotherapy planning of lung tumors: a comparison of virtual fluoroscopy and 4DCTYlanga G van der Geld, Suresh Senan, John R van Sörnsen de Koste, et al.
The Lancet. Oncology|April 24, 2009
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trialCécile Le Péchoux, Ariane Dunant, Suresh Senan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2009
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring studyFemke O B Spoelstra, Suresh Senan, Cecile Le Péchoux, et al.
Journal of Radiation Oncology|August 30, 2016
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challengeEmma Holliday, Clifton D Fuller, Jayashree Kalpathy-Cramer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinomaYlanga G van der Geld, Baukelien van Triest, Wilko F A R Verbakel, et al.
Expert Opinion on Biological Therapy|September 22, 2016
Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Paolo A Ascierto, Massimo C P Barberis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2020
Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastasesJohn R van Sörnsen de Koste, Miguel A Palacios, Hanbo Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung CancerHilâl Tekatli, Niels Haasbeek, Max Dahele, et al.
Chest|May 24, 2014
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysisAlexander V Louie, Suresh Senan, Pretesh Patel, et al.
Pageof 35